コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dies indicate the potential involvement of a CC chemokine receptor.
2 gesting that MIP-3alpha acts through a novel CC chemokine receptor.
3 ne receptor CXCR4 as well as to a variety of CC chemokine receptors.
4 n L1.2 cells tranfected with seven different CC chemokine receptors.
5 unusual among known CC chemokines and known CC chemokine receptors.
6 cture (CLP), blood PMN demonstrated mRNA for CC chemokine receptors.
7 is an orphan receptor with homology to other CC chemokine receptors.
10 nal down-modulation of the RANTES receptors, CC chemokine receptor 1 and CC chemokine receptor 5, dur
13 cal laser scanning microscopy showed reduced CC chemokine receptor 1, but not CC chemokine receptor 5
14 inal tail), and 2) the N-terminal segment of CC chemokine receptor 1, which does not bind CXC chemoki
16 essing a hemagglutinin-tagged version of the CC-chemokine receptor 1 (CCR1), and using these reagents
17 dial smooth muscle cells, express functional CC chemokine receptor-1 (CCR1) and respond to RANTES by
19 ession (IL-2, -4, -6, -10, and IFN-gamma and CC chemokine receptor-1 [CCR1]) was assayed in the lymph
20 uctures of PXR LBD with Adnectin-1 and CCR1 (CC chemokine receptor-1) antagonist Compound-1 were dete
22 m of vitamin D3, signaled T cells to express CC chemokine receptor 10, which enabled them to migrate
25 ing restrictions to a linear aminobutyramide CC chemokine receptor 2 (CCR2) antagonist lead (2) led t
26 ocyte chemotactic protein-1 [MCP-1]) and its CC chemokine receptor 2 (CCR2) are critical regulators o
29 n the present study we addressed the role of CC chemokine receptor 2 (CCR2) in M. tuberculosis infect
34 with relatively high numbers of parasites in CC chemokine receptor 2 (CCR2) KO mice, indicating that
35 dels that the expression of the inflammatory CC chemokine receptor 2 (CCR2) on donor-derived CD8+ T c
39 CC chemokine ligand 2 (CCL2), a ligand of CC chemokine receptor 2 (CCR2), is essential to mount an
40 man brain microvessels, which suggested that CC chemokine receptor 2 (CCR2), the recognized receptor
43 ice was reduced by 67%, but was unaltered in CC chemokine receptor 2(-/-) (CCR2(-/-)), CCR3(-/-), or
44 ory chemokine/receptor and cytokines (MCP-1, CC chemokine receptor 2, and interleukins 1beta and 6),
45 are rapidly mobilized upon inflammation in a CC-chemokine receptor 2-dependent manner, and the noncla
46 6- and 2.4-fold increases in Ly6-C(high) and CC-chemokine receptor 2-positive cells in lesions of apo
50 axin induces chemotaxis mediated through the CC chemokine receptor 3 (CCR3) present on basophils as w
53 g with our previously described(20) class of CC chemokine receptor-3 (CCR3) antagonist, we improved t
54 Eotaxin and other CC chemokines acting via CC chemokine receptor-3 (CCR3) are believed to play an i
56 This study demonstrates that expression of CC chemokine receptor 4 (CCR4) by DCs is required for EA
58 ive of this study was to examine the role of CC chemokine receptor 4 (CCR4) in macrophage polarizatio
61 ve also examined the interaction of MDC with CC chemokine receptor 4 (CCR4), recently shown to be a r
62 amulizumab, a defucosylated, humanized, anti-CC chemokine receptor 4 monoclonal antibody, in 41 pretr
66 ssion of coreceptors, cytokine regulation of CC chemokine receptor 5 (CCR5) and CD4 expression on mon
69 matory proteins 1alpha and 1beta to activate CC chemokine receptor 5 (CCR5) and the ability to inhibi
71 independent of the presence of a mutation in CC chemokine receptor 5 (CCR5) associated with resistanc
75 of a 32 bp deletion (Delta32) allele of the CC chemokine receptor 5 (CCR5) gene are reported to be m
77 n the present study, we explored the role of CC chemokine receptor 5 (CCR5) in a murine model of chro
86 us 24-bp deletion (Delta24) was found in the CC chemokine receptor 5 (CCR5) of 11 out of 15 red-cappe
87 f the viral envelope glycoprotein gp120 with CC chemokine receptor 5 (CCR5) or CXC chemokine receptor
88 eptor, CD4, and through a coreceptor, either CC chemokine receptor 5 (CCR5) or CXC chemokine receptor
89 glycoproteins, CD4 and a coreceptor, usually CC chemokine receptor 5 (CCR5) or CXC receptor 4 (CXCR4)
90 We demonstrate that signaling through the CC chemokine receptor 5 (CCR5) prevents uncontrolled pos
91 laria-infected women contain 3 times as much CC chemokine receptor 5 (CCR5) RNA as placentas of women
92 s of HIV-1 require the cell-surface receptor CC chemokine receptor 5 (CCR5) to infect specific leukoc
93 globulin (Ig) G4 monoclonal antibody against CC chemokine receptor 5 (CCR5) with robust in vitro acti
94 a32, a complete loss-of-function mutation in CC chemokine receptor 5 (CCR5), has been previously asso
95 of both CXC chemokine receptor 4 (CXCR4) and CC chemokine receptor 5 (CCR5), major coreceptors for T
100 8-coated beads are resistant to infection by CC chemokine receptor 5 (CCR5)-dependent HIV-1 isolates.
101 -SIGN1 is expressed on endothelial cells and CC chemokine receptor 5 (CCR5)-positive macrophage-like
107 normal CD45 splicing and the presence of the CC chemokine receptor 5 deletion 32 (CCR5del32) allele,
108 SIV hosts from AIDS and the discovery of low CC chemokine receptor 5 expression on CD4+ T cells as a
111 wed reduced CC chemokine receptor 1, but not CC chemokine receptor 5, expression by HaCaT cells at lo
112 viral burden and further implicate roles for CC chemokine receptor 5, macrophages, and Vpr in the lif
113 ll expressed and secreted), a ligand for the CC chemokine receptor 5, potently inhibits HIV-1 replica
114 macaques with CXC chemokine receptor 4- and CC chemokine receptor 5-specific simian/human immunodefi
116 iruses were found to play important roles in CC-chemokine receptor 5 (CCR5) coreceptor utilization, a
119 t on macrophagetropic viruses that enter via CC-chemokine receptor 5 (CCR5), despite binding to the s
121 chemokine receptor 4 (CXCR4), but not of the CC-chemokine receptor 5 in purified populations of prima
122 detected for galactosyl ceramide but not for CC-chemokine receptor 5, CXC-chemokine receptor 4, or CD
126 r gut homing, as indicated by high levels of CC chemokine receptor 6 and integrin beta7 expression.
131 that, even when LN retention signals such as CC chemokine receptor 7 (CCR7) are down-regulated, T cel
133 s T helper 1 (Th1) effector memory cells and CC chemokine receptor 7 (CCR7)(+) cells resembling centr
135 ndary lymphoid chemokine (SLC), a ligand for CC chemokine receptor 7 (CCR7), has been demonstrated to
136 by functional deletion (desensitization) of CC chemokine receptor 7 (CCR7), the receptor for SLC and
139 CD27Lo CD28Lo CD45RA- CD62 ligand- (CD62L-) CC chemokine receptor 7- (CCR7-) interleukin-7 receptor
140 that migration to lymph nodes occurred in a CC chemokine receptor 7-independent manner but, overall,
143 otaxis assay system, we demonstrate that the CC chemokine receptor-7 (CCR7) ligands 6Ckine and macrop
147 chemokine ligand 18 (CCL18), acting through CC chemokine receptor 8 (CCR8) on mononuclear cells, was
148 svirus (KSHV) that selectively activates the CC chemokine receptor 8 (CCR8), for which the endogenous
149 sm depended on alpha(4) beta(7) integrin and CC chemokine receptor 9 (CCR9) expression by LSEC-primed
151 Here we report that GPR-9-6, now called CC chemokine receptor 9 (CCR9), is a receptor for thymus
154 re a gut-homing phenotype (alpha 4 beta 7(+) CC chemokine receptor 9(+)) and the capacity to home to
155 signaling by CC chemokine ligand 25 through CC chemokine receptor 9, and binding of the integrins al
156 r appears to be present in a large number of CC chemokine receptors and thereby could play a more gen
157 0), IL-1 binding proteins, G protein-coupled CC chemokine receptor, and epidermal growth factor-like
159 uitment upon exposure to DEPs and that these CC chemokine receptors are important in the DEP-induced
161 in human T cells selectively through CCR8, a CC chemokine receptor associated with Th2 lymphocytes.
162 used CCR3 as an entry cofactor, despite this CC chemokine receptor being expressed on the cell surfac
163 addition, we demonstrate that IL-15 induces CC chemokine receptors, but not CXC chemokine receptors,
164 or cells resulted in decreased expression of CC chemokine receptor (CCR) 1 and increased CCR7 express
165 icular, the content of T lymphocytes bearing CC chemokine receptor (CCR) 1, CCR3, and CCR5 receptors
166 nophil signaling molecules [eg, eotaxins and CC chemokine receptor (CCR) 3] in IL-13-mediated airway
168 CCR5Delta32, a 32-base pair deletion of the CC chemokine receptor (CCR) 5 gene, is associated with s
172 ne receptor messenger RNA (mRNA) expression, CC chemokine receptor (CCR) protein activation during th
173 points to cross-talk between FcepsilonRI and CC chemokine receptor (CCR)-mediated signaling pathways
174 Human melanoma cells frequently express CC chemokine receptor (CCR)10, a receptor whose ligand (
176 Mice deficient for the major MCP-1 receptor, CC chemokine receptor (CCR)2, did not develop EAE after
178 CD4 cells from allergic individuals express CC chemokine receptor (CCR)3 and CCR4 after expansion in
180 sted naloxone-induced down-regulation of the CC chemokine receptor (CCR)5 in NY1DD mice but not in co
182 xpression of CC chemokine ligand (CCL) 20, a CC chemokine receptor (CCR)6 ligand, in human keratinocy
188 re that vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8 that is preferentially expr
191 erized PMN priming and maturation factor, on CC-chemokine receptor (CCR) expression in PMN was invest
192 This study investigates whether cytokine and CC-chemokine receptor (CCR) production by DCs stimulated
194 n-1beta, monocyte chemoattractant protein-1, CC-chemokine receptor (CCR)-1, CCR2, CCR5, and F4/80) th
197 e biology, we investigated the expression of CC chemokine receptors CCR1, CCR2, CCR3, CCR5, CXCR3, an
198 The receptor cavity shares six residues with CC-chemokine receptors CCR1 through CCR4, while seven re
200 1, MCP-2, RANTES, MIG, IP-10, I-TAC, and two CC chemokine receptors CCR2 and CCR5 were highly express
202 blood vessels in the lungs by acting on the CC chemokine receptor CCR3, which is located on the leuk
210 reted), which are the natural ligands of the CC-chemokine receptor CCR5, inhibit replication of MT-2-
213 Among 11 surveyed chemokine receptors, only CC chemokine receptor (CCR5), CXC chemokine receptor (CX
215 A subset of CC chemokines, acting through CC chemokine receptors (CCRs) 1 to 5, is instrumental in
216 cells in the joint, mediated in part by such CC chemokine receptors (CCRs) as CCR2 and CCR5, respecti
217 iral protein competes with the host cellular CC-chemokine receptors (CCRs), reducing inflammation and
218 , interleukin 1 receptor (IL-1R), and type 8 CC-chemokine receptors; cytokine binding proteins (BP),
222 did translational studies to examine CXC and CC chemokine receptor expression by flow cytometry on ne
224 hemotaxis does not occur at the level of the CC chemokine receptor for MCP-1, CCR2, since MIF does no
225 description of functional promoters for any CC chemokine receptor gene, and we speculate that the co
229 EC is significant, more so as it and several CC chemokine receptors have been shown to serve as fusio
232 rotein-coupled receptors that includes other CC chemokine receptors, INCB3344 is at least 100-fold se
233 r, PAF did not provide sufficient signal for CC chemokine receptor ligand 2 (CCL2) production in cell
235 nines and tyrosines in the N-termini of many CC chemokine receptors suggests that these posttranslati
236 emonstrate that pUL21.5 protein is a soluble CC chemokine receptor that functions as a decoy to modul
237 ceptor US28 but do not express mRNA of other CC chemokine receptors that bind RANTES (CCR1, CCR4, CCR
238 etic ablation or pharmacologic inhibition of CC chemokine receptor type 2 (CCR2) reduced macrophage (
239 in rectal tissue (both P < .001), and plasma CC chemokine receptor type 5 (CCR5) ligand (macrophage-i
242 fected cells express mRNA of the CMV-encoded CC chemokine receptor US28 but do not express mRNA of ot
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。